Interestingly, monocyte-derived macrophages isolated from RA patients treated with TNF-inhibitors showed downregulation of surface markers typically associated with inflammation (e.g., CD40 and CD80) but also upregulation of Mer, hence suggesting that, upon treatment, cells acquire the same anti-inflammatory properties as other Mer-positive macrophages. This evidence concerns the gene TNF and rheumatoid arthritis.